According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is ยฃ0.53. In 2022 the company made an earnings per share (EPS) of ยฃ0.51 a decrease over its 2021 EPS that were of ยฃ0.75.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ0.57 | 12.03% |
2022 | ยฃ0.51 | -32.67% |
2021 | ยฃ0.75 | -16.9% |
2020 | ยฃ0.91 | 2.54% |
2019 | ยฃ0.88 | 19.37% |
2018 | ยฃ0.74 | 98.42% |
2017 | ยฃ0.37 | 41.84% |
2016 | ยฃ0.26 | 1227.12% |
2015 | ยฃ0.01984 | -117.81% |
2014 | -ยฃ0.11 | 184.25% |
2013 | -ยฃ0.03920 | -12.81% |
2012 | -ยฃ0.04496 | -433.93% |
2011 | ยฃ0.01346 | -126.14% |
2010 | -ยฃ0.05150 | -258.4% |
2009 | ยฃ0.03251 |